-
May 09, 2013
Teva's partnership with Alexza looks like an expensive gamble.
-
February 14, 2013
Mylan (MYL) extended its three-year old partnership with India-based Biocon Limited. The companies recently signed a ...
-
February 14, 2013
Peregrine Pharmaceuticals (PPHM) recently announced phase II data on its oncology candidate, bavituximab. The ...
-
February 13, 2013
Roche (RHHBY) recently entered into a drug discovery collaboration with privately-held RQx Pharmaceuticals, Inc. ...
-
February 13, 2013
Shire plc (SHPG) recently settled its pending litigation with Impax Laboratories, Inc. (IPXL). The litigation is ...
-
February 12, 2013
Cardiome Pharma Corp. (CRME) recently selected privately-held Quintiles for providing lifecycle safety and global ...
-
February 12, 2013
Shire plc (SHPG) recently announced that the company has initiated a phase III study to evaluate the efficacy and ...
-
February 11, 2013
Acorda Therapeutics, Inc. (ACOR) recently announced that data from preclinical studies evaluating glial growth ...
-
February 11, 2013
Novo Nordisk (NVO) recently faced a setback when the US Food and Drug Administration (FDA) declined to approve its ...
-
February 11, 2013
Eli Lilly and Company (LLY) recently provided an update on its rheumatoid arthritis candidate, tabalumab. The ...
-
February 11, 2013
Domestic stock funds garnered a whopping $21 billion in the initial four weeks of 2013, according to Lipper. This ...
-
February 06, 2013
GlaxoSmithKline (GSK) recently increased its holding in its consumer healthcare subsidiary in India, GlaxoSmithKline ...
-
February 06, 2013
Bayer's (BAYRY) Healthcare unit and Johnson & Johnson's (JNJ) Janssen Pharmaceuticals recently collaborated with ...
-
February 05, 2013
Ireland-based Shire plc (SHPG) recently announced that the company has reached an agreement in principle to resolve ...
-
February 04, 2013
AstraZeneca's (AZN) fourth-quarter 2012 core earnings of $1.56 per American Depositary Share (ADS) beat the Zacks ...
-
February 01, 2013
Allergan, Inc. (AGN) recently announced that it has commenced a cash tender offer to purchase all the shares of MAP ...
-
February 01, 2013
Roche Holdings Ltd. (RHHBY) recently reported 2012 results. Revenues grew 4% year over year to CHF 45.5 billion ...
-
February 01, 2013
Novo Nordisk (NVO) reported fourth quarter 2012 earnings of $1.83 per American Depository Receipt (ADR), up 21.2% ...
-
January 31, 2013
Repros Therapeutics Inc. (RPRX) recently announced that results from the first pivotal study (ZA-301) of Androxal ...
-
January 30, 2013
Roche (RHHBY) announced that its wholly owned subsidiary, Genentech, has recently inked a global licensing agreement ...
